Feds Host Virtual Bash to Brainstorm Animal-Free Chemical Testing
Published Date: 7/14/2025
Notice
Summary
The National Institute of Environmental Health Sciences is hosting a virtual meeting on September 11-12, 2025, about safer and smarter ways to test chemicals without using animals. Scientists, industry folks, and animal protection groups will share ideas, and the public can join, comment, or watch online. If you want to speak or need special help, register early—this meeting is all about making testing better and kinder, with no cost to attend!
Analyzed Economic Effects
4 provisions identified: 2 benefits, 2 costs, 0 mixed.
Virtual public meeting — free with registration
The Scientific Advisory Committee on Alternative Toxicological Methods will hold a virtual public meeting on September 11-12, 2025, from about 10:00 a.m. to 3:15 p.m. Eastern each day. You must register to view the webcast or to present oral comments, but there is no cost to attend.
Oral comments limited and first-come rule
If you want to present oral comments, registration is required and each public comment period allows five oral commenters. Only one representative per organization may present (if accepted), presentations are limited to five minutes, and registration is first-come, first-served with a wait list if slots fill.
Accommodations available; TTY info updated
Individuals who need special assistance—such as sign language interpretation or other reasonable accommodations—should notify the contact person at least five business days before the meeting; TTY users may use the Federal TTY Relay Service at 800-877-8339 or 711.
Written comments accepted; no government payment
Any interested person may file written comments for the committee; however, the notice states the U.S. Government will not pay for preparing submitted information or for its use. Information on submitting written comments is available at the meeting webpage.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14966, Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a new Ebola vaccine invention for companies to license and develop quickly. This vaccine targets the Bundibugyo virus and promises fast and lasting protection, helping stop outbreaks in Central Africa. Businesses interested in licensing should act soon to bring this life-saving tech to market and can contact NIH for details.
Previous / Next Documents
Previous: 2025-13050, Agency Information Collection Activities; Proposed Collection; Comment Request; Q-Submission and Early Payor Feedback Request Programs and Medical Device Development Tools
The FDA wants your thoughts on how they collect info about medical device feedback programs and tool qualifications. If you’re involved in making or paying for medical devices, this could affect you. They’re asking for comments over the next 60 days to help improve the process—no extra costs, just your input!
Next: 2025-13052, Agency Information Collection Activities; Proposed Collection; Comment Request; Electronic Products
The FDA wants to hear from manufacturers and distributors of electronic products about their reporting and recordkeeping rules. They’re asking for public comments over the next 60 days to make sure the information they collect is clear and useful. This helps keep things running smoothly without extra costs or confusion.